Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study

Backgroundextensive-stage small cell lung cancer (ES-SCLC) were the majority of SCLC patients. Recently the combination of chemotherapy with immune checkpoint inhibitors (ICIs) have emerged as the new first-line treatment standard for ES-SCLC. However, the specific patient populations that are most...

全面介绍

书目详细资料

Principais autores:	Bin Jia, Chenyi Zhou, Fei Zhao, Xiaoru Song, Yuan Ding, Xiyin Wang, Boying Wu, Huina Wang, Quanman Hu, Shuaiyin Chen
格式:	Artigo
语言:	Inglês
出版:	Frontiers Media S.A. 2025-08-01
丛编:	Frontiers in Immunology
主题:	ES-SCLC chemotherapy ICIs PSM COX prognostic
在线阅读:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1562458/full
标签:	添加标签 没有标签, 成为第一个标记此记录!